Literature DB >> 15630598

[Hereditary hemorrhagic telangiectasia. A rare treatable cause of stroke].

D Ecker1, U W Geisthoff, M Juchems, G Schneider, A C Ludolph, J Kassubek, R Huber.   

Abstract

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease of the vascular connective tissue. Pulmonary arteriovenous and cerebral vascular malformations are risk factors for serious neurological complications such as paradoxical embolism and intracranial hematomas. We describe two patients with HHT and pulmonary arteriovenous malformations suffering from stroke caused by paradoxical embolism. In both cases, fistulas were successfully treated by embolisation and no further cerebral ischemic events occurred. In ischemic strokes of unknown origin, HHT should be considered as a possible diagnosis with effective treatment options.

Entities:  

Mesh:

Year:  2005        PMID: 15630598     DOI: 10.1007/s00115-004-1859-4

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  10 in total

Review 1.  Hereditary hemorrhagic telangiectasia.

Authors:  A E Guttmacher; D A Marchuk; R I White
Journal:  N Engl J Med       Date:  1995-10-05       Impact factor: 91.245

2.  Prevalence of pulmonary arteriovenous malformations (PAVMs) and occurrence of neurological symptoms in patients with hereditary haemorrhagic telangiectasia (HHT).

Authors:  A D Kjeldsen; H Oxhøj; P E Andersen; A Green; P Vase
Journal:  J Intern Med       Date:  2000-09       Impact factor: 8.989

Review 3.  Progression of pulmonary arteriovenous malformation during pregnancy: case report and review of the literature.

Authors:  M S Esplin; M W Varner
Journal:  Obstet Gynecol Surv       Date:  1997-04       Impact factor: 2.347

4.  The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2.

Authors:  J N Berg; C J Gallione; T T Stenzel; D W Johnson; W P Allen; C E Schwartz; C E Jackson; M E Porteous; D A Marchuk
Journal:  Am J Hum Genet       Date:  1997-07       Impact factor: 11.025

5.  Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome).

Authors:  C L Shovlin; A E Guttmacher; E Buscarini; M E Faughnan; R H Hyland; C J Westermann; A D Kjeldsen; H Plauchu
Journal:  Am J Med Genet       Date:  2000-03-06

6.  Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm.

Authors:  C Lamy; C Giannesini; M Zuber; C Arquizan; J F Meder; D Trystram; J Coste; J L Mas
Journal:  Stroke       Date:  2002-03       Impact factor: 7.914

7.  Linkage of hereditary haemorrhagic telangiectasia to chromosome 9q34 and evidence for locus heterogeneity.

Authors:  P Heutink; T Haitjema; G J Breedveld; B Janssen; L A Sandkuijl; C J Bontekoe; C J Westerman; B A Oostra
Journal:  J Med Genet       Date:  1994-12       Impact factor: 6.318

8.  Hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease).

Authors:  Uichiro Fuchizaki; Hirotoshi Miyamori; Shunsuke Kitagawa; Shuichi Kaneko; Kenichi Kobayashi
Journal:  Lancet       Date:  2003-11-01       Impact factor: 79.321

Review 9.  [Hereditary hemorrhagic telangiectasia (Osler's disease). An interdisciplinary challenge].

Authors:  U W Geisthoff; G Schneider; J Fischinger; P K Plinkert
Journal:  HNO       Date:  2002-02       Impact factor: 1.284

10.  Isolated pulmonary arteriovenous fistula without Rendu-Osler-Weber disease as a cause of cryptogenic stroke.

Authors:  K Kimura; K Minematsu; M Nakajima
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.